Diabetes Enhanced
Virtual Workshops 20:00 - 21:30
Date:
Part 1: 14th October 2020 & Part 2: 4th November 2020
Cost:
Free
Virtual Workshops – Type 2 Diabetes Enhanced Programme – Supporting GP Pharmacists Already Managing Patients with Type 2 Diabetes to Implement Quality Improvement (QI)
The i2i Network is delighted to be continuing our collaboration with Napp Pharmaceuticals Limited to support GP Pharmacists by bringing an exciting programme designed to further develop competencies and skills in type 2 diabetes management.
These non-promotional webinars have been fully funded by Napp Pharmaceuticals Limited and organised by Soar Beyond. The agendas were developed by Soar Beyond in conjunction with Napp. Soar Beyond and the i2i faculty have developed the presentations independently from Napp, but Napp have reviewed the content for factual accuracy.
To learn more about how Napp protects your personal data, please refer to the Napp privacy notice by clicking here or copying and pasting the following link: https://napp.co.uk/privacy-notice/
Speakers
Agenda
Supported by
Speakers
Dr Patrick Holmes
Patrick is a GP partner in Darlington with a special interest in diabetes and is on the committee of the Primary Care Diabetes Society (PCDS). Patrick was involved in the design of the largest integrated diabetes service in the UK serving the population of Darlington and County Durham, and is now the Diabetes Clinical Lead for Tees Valley CCG, County Durham & Darlington Foundation Trust.
Read BioHannah Beba
Hannah Beba is a Senior Pharmacist for Diabetes and Endocrinology at County Durham and Darlington NHS Foundation Trust. Hannah retains a predominantly clinical role and is an independent prescriber. Hannah has been independently practicing in clinics for many years in diabetes/endocrine across both primary and secondary care.
Read BioMichelle Lam
A diabetes and endocrinology pharmacist at Hull and East Yorkshire Hospitals NHS Trust, Michelle is also a lecturer in pharmacy practice at the University of Bradford and a teacher practitioner for diabetes within the postgraduate clinical pharmacy diploma at the University of Manchester.
Read BioAgenda
By attending this live stream part 1, our expert speakers will explain and discuss:
1. The impact and management of type 2 diabetes patients with a focus on co-morbid frailty, CKD and/or ASCVD
2. What quality improvement (QI) is and how to implement effective QI in practice for these patients
3. What to do in the DIAGNOSE phase of QI using these patient cohorts
By attending this live stream part 2, our expert speakers will explain and discuss:
1. Share outcomes and challenges from DIAGNOSE activities
2. Consider QI DESIGN options appraisal and DELIVER plans
3. DEMONSTRATE OUTCOMES – establishing QI process and patient impact
Supported by
These non-promotional webinars have been fully funded by Napp Pharmaceuticals Limited and organised by Soar Beyond. The agendas were developed by Soar Beyond in conjunction with Napp. Soar Beyond and the i2i faculty have developed the presentations independently from Napp, but Napp have reviewed the content for factual accuracy.
To learn more about how Napp protects your personal data, please refer to the Napp privacy notice by clicking here or copying and pasting the following link: https://napp.co.uk/privacy-notice/
UK/DIA-20110af
Date of Preparation September 2020
This workshop has already taken place.